Regarding skin cancer, ILC3s showed a role in melanoma immunosurveillance, for example, in vivo experiments with B-16 melanoma cells demonstrated that NKp46+ILC3s cells (called at that moment Ltis) play a significant anti-tumor role in presence of IL-12 (35) (Figure 2). This evidence concerns the gene NCR1 and neoplasm.